BRISTOL-MYERS SQUIBB CO (BMY) Fundamental Analysis & Valuation
NYSE:BMY • US1101221083
Current stock price
60.59 USD
+3 (+5.21%)
At close:
60.1422 USD
-0.45 (-0.74%)
After Hours:
This BMY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. BMY Profitability Analysis
1.1 Basic Checks
- BMY had positive earnings in the past year.
- BMY had a positive operating cash flow in the past year.
- Of the past 5 years BMY 4 years were profitable.
- BMY had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- BMY has a Return On Assets of 7.83%. This is amongst the best in the industry. BMY outperforms 87.96% of its industry peers.
- BMY's Return On Equity of 38.19% is amongst the best of the industry. BMY outperforms 96.86% of its industry peers.
- With an excellent Return On Invested Capital value of 19.12%, BMY belongs to the best of the industry, outperforming 95.81% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for BMY is in line with the industry average of 13.07%.
- The last Return On Invested Capital (19.12%) for BMY is above the 3 year average (14.33%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.83% | ||
| ROE | 38.19% | ||
| ROIC | 19.12% |
ROA(3y)2.2%
ROA(5y)3.91%
ROE(3y)3.56%
ROE(5y)10.1%
ROIC(3y)14.33%
ROIC(5y)12.84%
1.3 Margins
- Looking at the Profit Margin, with a value of 14.64%, BMY belongs to the top of the industry, outperforming 87.96% of the companies in the same industry.
- BMY's Profit Margin has improved in the last couple of years.
- BMY's Operating Margin of 35.09% is amongst the best of the industry. BMY outperforms 96.34% of its industry peers.
- BMY's Operating Margin has improved in the last couple of years.
- BMY has a better Gross Margin (72.63%) than 80.10% of its industry peers.
- In the last couple of years the Gross Margin of BMY has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 35.09% | ||
| PM (TTM) | 14.64% | ||
| GM | 72.63% |
OM growth 3Y12.45%
OM growth 5Y20.1%
PM growth 3Y2.21%
PM growth 5YN/A
GM growth 3Y-2.43%
GM growth 5Y-0.33%
2. BMY Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so BMY is creating value.
- The number of shares outstanding for BMY has been increased compared to 1 year ago.
- Compared to 5 years ago, BMY has less shares outstanding
- Compared to 1 year ago, BMY has an improved debt to assets ratio.
2.2 Solvency
- BMY has an Altman-Z score of 2.48. This is not the best score and indicates that BMY is in the grey zone with still only limited risk for bankruptcy at the moment.
- The Altman-Z score of BMY (2.48) is better than 62.83% of its industry peers.
- BMY has a debt to FCF ratio of 3.51. This is a good value and a sign of high solvency as BMY would need 3.51 years to pay back of all of its debts.
- Looking at the Debt to FCF ratio, with a value of 3.51, BMY belongs to the top of the industry, outperforming 89.01% of the companies in the same industry.
- BMY has a Debt/Equity ratio of 2.33. This is a high value indicating a heavy dependency on external financing.
- BMY has a worse Debt to Equity ratio (2.33) than 82.72% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.33 | ||
| Debt/FCF | 3.51 | ||
| Altman-Z | 2.48 |
ROIC/WACC2.11
WACC9.05%
2.3 Liquidity
- BMY has a Current Ratio of 1.26. This is a normal value and indicates that BMY is financially healthy and should not expect problems in meeting its short term obligations.
- The Current ratio of BMY (1.26) is worse than 80.10% of its industry peers.
- BMY has a Quick Ratio of 1.14. This is a normal value and indicates that BMY is financially healthy and should not expect problems in meeting its short term obligations.
- BMY has a Quick ratio of 1.14. This is in the lower half of the industry: BMY underperforms 78.53% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.14 |
3. BMY Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 439.47% over the past year.
- BMY shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -0.92% yearly.
- Looking at the last year, BMY shows a decrease in Revenue. The Revenue has decreased by -0.22% in the last year.
- The Revenue has been growing slightly by 2.54% on average over the past years.
EPS 1Y (TTM)439.47%
EPS 3Y-7.62%
EPS 5Y-0.92%
EPS Q2Q%-24.55%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y1.45%
Revenue growth 5Y2.54%
Sales Q2Q%1.3%
3.2 Future
- The Earnings Per Share is expected to decrease by -4.46% on average over the next years.
- BMY is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -5.58% yearly.
EPS Next Y2.96%
EPS Next 2Y0.32%
EPS Next 3Y-4.23%
EPS Next 5Y-4.46%
Revenue Next Year-1.82%
Revenue Next 2Y-2.01%
Revenue Next 3Y-5.44%
Revenue Next 5Y-5.58%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. BMY Valuation Analysis
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 9.85, the valuation of BMY can be described as reasonable.
- Compared to the rest of the industry, the Price/Earnings ratio of BMY indicates a rather cheap valuation: BMY is cheaper than 92.67% of the companies listed in the same industry.
- BMY is valuated cheaply when we compare the Price/Earnings ratio to 26.77, which is the current average of the S&P500 Index.
- The Price/Forward Earnings ratio is 9.57, which indicates a very decent valuation of BMY.
- Based on the Price/Forward Earnings ratio, BMY is valued cheaper than 89.53% of the companies in the same industry.
- BMY is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.75, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.85 | ||
| Fwd PE | 9.57 |
4.2 Price Multiples
- BMY's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BMY is cheaper than 92.15% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, BMY is valued cheaply inside the industry as 93.72% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.63 | ||
| EV/EBITDA | 7.23 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- The excellent profitability rating of BMY may justify a higher PE ratio.
- A cheap valuation may be justified as BMY's earnings are expected to decrease with -4.23% in the coming years.
PEG (NY)3.33
PEG (5Y)N/A
EPS Next 2Y0.32%
EPS Next 3Y-4.23%
5. BMY Dividend Analysis
5.1 Amount
- BMY has a Yearly Dividend Yield of 4.38%, which is a nice return.
- Compared to an average industry Dividend Yield of 0.73, BMY pays a better dividend. On top of this BMY pays more dividend than 96.34% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.82, BMY pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.38% |
5.2 History
- The dividend of BMY is nicely growing with an annual growth rate of 6.51%!
- BMY has been paying a dividend for at least 10 years, so it has a reliable track record.
- BMY has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)6.51%
Div Incr Years4
Div Non Decr Years4
5.3 Sustainability
- BMY pays out 71.52% of its income as dividend. This is not a sustainable payout ratio.
- BMY's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP71.52%
EPS Next 2Y0.32%
EPS Next 3Y-4.23%
BMY Fundamentals: All Metrics, Ratios and Statistics
60.59
+3 (+5.21%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Industry Strength65.84
Industry Growth15.53
Earnings (Last)04-30 2026-04-30/bmo
Earnings (Next)07-30 2026-07-30
Inst Owners83.83%
Inst Owner Change0.6%
Ins Owners0.03%
Ins Owner Change1.98%
Market Cap123.71B
Revenue(TTM)48.19B
Net Income(TTM)7.05B
Analysts70.56
Price Target63.21 (4.32%)
Short Float %1.59%
Short Ratio2.71
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.38% |
Yearly Dividend2.51
Dividend Growth(5Y)6.51%
DP71.52%
Div Incr Years4
Div Non Decr Years4
Ex-Date04-02 2026-04-02 (0.63)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.39%
Min EPS beat(2)6.92%
Max EPS beat(2)11.85%
EPS beat(4)4
Avg EPS beat(4)18.29%
Min EPS beat(4)6.92%
Max EPS beat(4)35.04%
EPS beat(8)8
Avg EPS beat(8)16.75%
EPS beat(12)11
Avg EPS beat(12)12.26%
EPS beat(16)15
Avg EPS beat(16)10.82%
Revenue beat(2)2
Avg Revenue beat(2)1.61%
Min Revenue beat(2)0.79%
Max Revenue beat(2)2.43%
Revenue beat(4)4
Avg Revenue beat(4)3.42%
Min Revenue beat(4)0.79%
Max Revenue beat(4)6.79%
Revenue beat(8)8
Avg Revenue beat(8)3.86%
Revenue beat(12)9
Avg Revenue beat(12)1.94%
Revenue beat(16)12
Avg Revenue beat(16)1.77%
PT rev (1m)1.9%
PT rev (3m)11.07%
EPS NQ rev (1m)-1.81%
EPS NQ rev (3m)0.13%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)4.3%
Revenue NQ rev (1m)0.15%
Revenue NQ rev (3m)3.29%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)6.9%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.85 | ||
| Fwd PE | 9.57 | ||
| P/S | 2.57 | ||
| P/FCF | 9.63 | ||
| P/OCF | 8.74 | ||
| P/B | 6.7 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.23 |
EPS(TTM)6.15
EY10.15%
EPS(NY)6.33
Fwd EY10.45%
FCF(TTM)6.29
FCFY10.38%
OCF(TTM)6.93
OCFY11.44%
SpS23.6
BVpS9.05
TBVpS-10.96
PEG (NY)3.33
PEG (5Y)N/A
Graham Number35.3832 (-41.6%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.83% | ||
| ROE | 38.19% | ||
| ROCE | 25.39% | ||
| ROIC | 19.12% | ||
| ROICexc | 22.75% | ||
| ROICexgc | 83.21% | ||
| OM | 35.09% | ||
| PM (TTM) | 14.64% | ||
| GM | 72.63% | ||
| FCFM | 26.65% |
ROA(3y)2.2%
ROA(5y)3.91%
ROE(3y)3.56%
ROE(5y)10.1%
ROIC(3y)14.33%
ROIC(5y)12.84%
ROICexc(3y)17.09%
ROICexc(5y)15.28%
ROICexgc(3y)71.55%
ROICexgc(5y)85.11%
ROCE(3y)19.02%
ROCE(5y)17.03%
ROICexgc growth 3Y-4.44%
ROICexgc growth 5Y13.26%
ROICexc growth 3Y20.37%
ROICexc growth 5Y33.41%
OM growth 3Y12.45%
OM growth 5Y20.1%
PM growth 3Y2.21%
PM growth 5YN/A
GM growth 3Y-2.43%
GM growth 5Y-0.33%
F-Score7
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.33 | ||
| Debt/FCF | 3.51 | ||
| Debt/EBITDA | 2.06 | ||
| Cap/Depr | 32.69% | ||
| Cap/Sales | 2.72% | ||
| Interest Coverage | 8.05 | ||
| Cash Conversion | 67.65% | ||
| Profit Quality | 182.1% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.14 | ||
| Altman-Z | 2.48 |
F-Score7
WACC9.05%
ROIC/WACC2.11
Cap/Depr(3y)19.36%
Cap/Depr(5y)15.61%
Cap/Sales(3y)2.66%
Cap/Sales(5y)2.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)439.47%
EPS 3Y-7.62%
EPS 5Y-0.92%
EPS Q2Q%-24.55%
EPS Next Y2.96%
EPS Next 2Y0.32%
EPS Next 3Y-4.23%
EPS Next 5Y-4.46%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y1.45%
Revenue growth 5Y2.54%
Sales Q2Q%1.3%
Revenue Next Year-1.82%
Revenue Next 2Y-2.01%
Revenue Next 3Y-5.44%
Revenue Next 5Y-5.58%
EBIT growth 1Y46.5%
EBIT growth 3Y14.08%
EBIT growth 5Y23.15%
EBIT Next Year23.35%
EBIT Next 3Y2.42%
EBIT Next 5Y-1.3%
FCF growth 1Y-7.87%
FCF growth 3Y2.44%
FCF growth 5Y-0.69%
OCF growth 1Y-6.81%
OCF growth 3Y2.71%
OCF growth 5Y0.15%
BRISTOL-MYERS SQUIBB CO / BMY Fundamental Analysis FAQ
What is the ChartMill fundamental rating of BRISTOL-MYERS SQUIBB CO (BMY) stock?
ChartMill assigns a fundamental rating of 6 / 10 to BMY.
What is the valuation status for BMY stock?
ChartMill assigns a valuation rating of 8 / 10 to BRISTOL-MYERS SQUIBB CO (BMY). This can be considered as Undervalued.
How profitable is BRISTOL-MYERS SQUIBB CO (BMY) stock?
BRISTOL-MYERS SQUIBB CO (BMY) has a profitability rating of 9 / 10.
What is the valuation of BRISTOL-MYERS SQUIBB CO based on its PE and PB ratios?
The Price/Earnings (PE) ratio for BRISTOL-MYERS SQUIBB CO (BMY) is 9.85 and the Price/Book (PB) ratio is 6.7.
What is the earnings growth outlook for BRISTOL-MYERS SQUIBB CO?
The Earnings per Share (EPS) of BRISTOL-MYERS SQUIBB CO (BMY) is expected to grow by 2.96% in the next year.